|
KIAA0754 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03089994716055E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05470000510977E-08 |
| Normal-vs-Stage2 |
9.40399999982411E-07 |
| Normal-vs-Stage3 |
5.46650003041549E-09 |
| Normal-vs-Stage4 |
3.48689965790072E-11 |
| Stage1-vs-Stage2 |
5.643800E-01 |
| Stage1-vs-Stage3 |
5.727800E-01 |
| Stage1-vs-Stage4 |
1.341050E-03 |
| Stage2-vs-Stage3 |
3.313200E-01 |
| Stage2-vs-Stage4 |
1.457520E-02 |
| Stage3-vs-Stage4 |
3.308000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03389999894787E-08 |
| Normal-vs-AfricanAmerican |
1.99890000107672E-08 |
| Normal-vs-Asian |
1.32569999422572E-09 |
| Caucasian-vs-AfricanAmerican |
6.012400E-01 |
| Caucasian-vs-Asian |
1.404240E-01 |
| AfricanAmerican-vs-Asian |
4.976400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.06079963993977E-10 |
| Normal-vs-Female |
1.03470000345496E-08 |
| Male-vs-Female |
7.137800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.99999999578915E-09 |
| Normal-vs-Age(41-60Yrs) |
1.14799999506587E-08 |
| Normal-vs-Age(61-80Yrs) |
1.44300005278097E-09 |
| Normal-vs-Age(81-100Yrs) |
1.730130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.382600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.599200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.612200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.478600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.297400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.836400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.476550E-03 |
| Classical-VS-Follicular |
7.392800E-01 |
| Classical-VS-Other |
8.060400E-03 |
| Classical-VS-Normal |
1.32159999610693E-08 |
| Tall-VS-Follicular |
1.692040E-02 |
| Tall-VS-Other |
3.570800E-01 |
| Tall-VS-Normal |
5.02680119751631E-11 |
| Follicular-VS-Other |
8.078600E-03 |
| Follicular-VS-Normal |
6.79849999629667E-08 |
| Other-VS-Normal |
1.23770005355794E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33369999488764E-08 |
| Normal-vs-N1 |
4.58619997534271E-09 |
| N0-vs-N1 |
2.702800E-01 |
|
|
